<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">clinvest</journal-id><journal-title-group><journal-title xml:lang="ru">Качественная клиническая практика</journal-title><trans-title-group xml:lang="en"><trans-title>Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2588-0519</issn><issn pub-type="epub">2618-8473</issn><publisher><publisher-name>ООО «Издательство ОКИ</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">clinvest-387</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КАЧЕСТВО ЖИЗНИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>QUALITY OF LIFE</subject></subj-group></article-categories><title-group><article-title>Качество жизни и антибактериальная терапия</article-title><trans-title-group xml:lang="en"><trans-title></trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мухина</surname><given-names>М. А.</given-names></name></name-alternatives><bio xml:lang="ru"><p>кафедра клинической фармакологии</p></bio><email xlink:type="simple">clinvest@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Манешина</surname><given-names>О. А.</given-names></name></name-alternatives><bio xml:lang="ru"><p>кафедра клинической фармакологии</p></bio><email xlink:type="simple">clinvest@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff xml:lang="ru" id="aff-1"><institution>Российский государственный медицинский университет, г. Москва</institution><country>Russian Federation</country></aff><pub-date pub-type="collection"><year>2004</year></pub-date><pub-date pub-type="epub"><day>02</day><month>07</month><year>2018</year></pub-date><volume>0</volume><issue>1</issue><fpage>13</fpage><lpage>15</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Мухина М.А., Манешина О.А., 2018</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="ru">Мухина М.А., Манешина О.А.</copyright-holder><copyright-holder xml:lang="en">Мухина М.А., Манешина О.А.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.clinvest.ru/jour/article/view/387">https://www.clinvest.ru/jour/article/view/387</self-uri><abstract><p>Существенный прогресс фармакологии во второй половине XX в. привел к появлению огромного числа лекарственных препаратов. Примером могут служить антибактериальные препараты, список которых непрерывно расширяется. В большинстве случаев изменения качества жизни при фармакотерапии оказываются не столь значительными, однако и они могут повлиять на результаты терапии. Цель данного обзора заключается в кратком освещении общихвопросов, касающихся качества жизни, кроме того, в статье приведены некоторые результаты исследования качества жизни пациентов при проведении антибактериальной терапии.</p></abstract><kwd-group xml:lang="ru"><kwd>качество жизни</kwd><kwd>антибактериальная терапия</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Белоусов Ю.Б., Моисеев В.С., Лепахин В.К. Клиническая фармакология и фармакотерапия. 2003 г. Гл. 6 (Лекарства и качество жизни).</mixed-citation><mixed-citation xml:lang="en">Белоусов Ю.Б., Моисеев В.С., Лепахин В.К. Клиническая фармакология и фармакотерапия. 2003 г. Гл. 6 (Лекарства и качество жизни).</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Петрова Н.Н. IV Конференция Международного общества исследования качества жизни. Улучшение качества жизни цель здравоохранения. Нефрология, 1998; 2; 2: 145-146.</mixed-citation><mixed-citation xml:lang="en">Петрова Н.Н. IV Конференция Международного общества исследования качества жизни. Улучшение качества жизни цель здравоохранения. Нефрология, 1998; 2; 2: 145-146.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Gollinelli D. Role of Quality of Life studies in the Reimbursement of Medicines Quality of Life 1998.</mixed-citation><mixed-citation xml:lang="en">Gollinelli D. Role of Quality of Life studies in the Reimbursement of Medicines Quality of Life 1998.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Формулярная система. Приложение к журналу «Пульмонология», 1994.</mixed-citation><mixed-citation xml:lang="en">Формулярная система. Приложение к журналу «Пульмонология», 1994.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Rechtweg J.S., Moinuddin R., Houser S.M., Mamikoglu B., Corey J.P. Quality of life in treatment of acute rhinosinusitis with clarithromycin and amoxicillin/clavulanate. Laryngoscope. 2004, May;114(5):806_10.</mixed-citation><mixed-citation xml:lang="en">Rechtweg J.S., Moinuddin R., Houser S.M., Mamikoglu B., Corey J.P. Quality of life in treatment of acute rhinosinusitis with clarithromycin and amoxicillin/clavulanate. Laryngoscope. 2004, May;114(5):806_10.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Foy S.P.; Shugars D.A.; Phillips C.; Marciani R.D.; Conrad S.M.; White R.P. The impact of intravenous antibiotics on health related quality of life outcomes and clinical recovery after third molar surgery. J Oral Maxillofac Surg 2004 Jan;62(1):15-21.</mixed-citation><mixed-citation xml:lang="en">Foy S.P.; Shugars D.A.; Phillips C.; Marciani R.D.; Conrad S.M.; White R.P. The impact of intravenous antibiotics on health related quality of life outcomes and clinical recovery after third molar surgery. J Oral Maxillofac Surg 2004 Jan;62(1):15-21.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Goodfellow AF; Wai AO; Frighetto L; Marra CA; Ferreira BM; Chase ML; Nicol RE; Leong CA; Tomlinson S., Jewesson P.J. Quality of life assessment in an outpatient parenteral antibiotic program. Ann Pharmacother, 2002 Dec; 36(12):1851-5.</mixed-citation><mixed-citation xml:lang="en">Goodfellow AF; Wai AO; Frighetto L; Marra CA; Ferreira BM; Chase ML; Nicol RE; Leong CA; Tomlinson S., Jewesson P.J. Quality of life assessment in an outpatient parenteral antibiotic program. Ann Pharmacother, 2002 Dec; 36(12):1851-5.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Quittner A.L., Buu A. Effects of tobramycin solution for inhalation on global ratings of quality of life in patients with cystic fibrosis and Pseudomonas aeruginosa infection. Pediatr Pulmonol. 2002 Apr.;33(4):269-76.</mixed-citation><mixed-citation xml:lang="en">Quittner A.L., Buu A. Effects of tobramycin solution for inhalation on global ratings of quality of life in patients with cystic fibrosis and Pseudomonas aeruginosa infection. Pediatr Pulmonol. 2002 Apr.;33(4):269-76.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Wolter J., Seeney S., Bell S., Bowler S., Masel P., McCormack J. Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomized trial. Thorax. 2002, Mar;57(3):212-6.</mixed-citation><mixed-citation xml:lang="en">Wolter J., Seeney S., Bell S., Bowler S., Masel P., McCormack J. Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomized trial. Thorax. 2002, Mar;57(3):212-6.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Yamaguchi H., Uchino K., Yokoyama H., Matsumoto T., Odagiri S. Use of the antibacterial agent levofloxacin for acute upper respiratory tract infection accompanied by fever. Jpn J Antibiot. 2003 Dec;56(6):719-36.</mixed-citation><mixed-citation xml:lang="en">Yamaguchi H., Uchino K., Yokoyama H., Matsumoto T., Odagiri S. Use of the antibacterial agent levofloxacin for acute upper respiratory tract infection accompanied by fever. Jpn J Antibiot. 2003 Dec;56(6):719-36.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Torres A., Muir J.F., Corris P., Kubin R., Duprat-Lomon I., Sagnier P.P., Hoffken G. Effectiveness of oral moxifloxacin in standard first-line therapy in community acquired pneumonia. Eur Respir J. 2003 Jan; 21(1):135-43.</mixed-citation><mixed-citation xml:lang="en">Torres A., Muir J.F., Corris P., Kubin R., Duprat-Lomon I., Sagnier P.P., Hoffken G. Effectiveness of oral moxifloxacin in standard first-line therapy in community acquired pneumonia. Eur Respir J. 2003 Jan; 21(1):135-43.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Laine L., Dhir V. Helicobacter pylori eradication does not worsen quality of life related to reflux symptoms: a prospective trial. Aliment Pharmacol Ther. 2002 Jun;16(6):1143-8.</mixed-citation><mixed-citation xml:lang="en">Laine L., Dhir V. Helicobacter pylori eradication does not worsen quality of life related to reflux symptoms: a prospective trial. Aliment Pharmacol Ther. 2002 Jun;16(6):1143-8.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Moayyedi P., Feltbower R., Brown J., Mason S., Mason J., Nathan J., Richards I.D., Dowell A.C., Axon A.T. Effect of population screening and treatment for Helicobacter pylori on dyspepsia and quality of life in the community: a randomized controlled trial. Leeds HELP Study Group. Lancet. 2000 May 13;355(9216):1665-9.</mixed-citation><mixed-citation xml:lang="en">Moayyedi P., Feltbower R., Brown J., Mason S., Mason J., Nathan J., Richards I.D., Dowell A.C., Axon A.T. Effect of population screening and treatment for Helicobacter pylori on dyspepsia and quality of life in the community: a randomized controlled trial. Leeds HELP Study Group. Lancet. 2000 May 13;355(9216):1665-9.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Wolter J.M., Cagney R.A., McCormack J.G. A randomized trial of home vs hospital intravenous antibiotic therapy in adults with infectious diseases. J Infect. 2004 Apr;48(3):263-8.</mixed-citation><mixed-citation xml:lang="en">Wolter J.M., Cagney R.A., McCormack J.G. A randomized trial of home vs hospital intravenous antibiotic therapy in adults with infectious diseases. J Infect. 2004 Apr;48(3):263-8.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
